Hepatic CMV-IE expression and distribution further defines the aetiological and prognostic subtypes of biliary atresia
Topic overview
This study examines CMV immediate-early protein expression in liver tissue from biliary atresia patients to identify viral replication patterns that may predict outcomes after Kasai portoenterostomy. Findings could help stratify BA patients by aetiology and prognosis based on hepatic CMV-IE distribution.
Key takeaways
- CMV-IE protein expression in liver tissue indicates active viral replication and may identify BA patients with ongoing CMV involvement.
- CMV-IE distribution patterns in hepatic tissue can stratify BA into aetiological subtypes with distinct pathogenic mechanisms.
- Hepatic CMV-IE levels correlate with post-KPE outcomes, offering prognostic value for surgical planning and follow-up intensity.
- CMV-IE assessment provides objective biomarker data beyond serology, enabling more precise patient stratification in BA management.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Hepatic CMV-IE expression and distribution further defines the aetiological and prognostic subtypes of biliary atresia. GlobalCastMD Medical Library. 2026-02-02. https://library.globalcastmd.com/article/11448?via_space=staycurrentmd
Comments